Vimarsana
Biggest News Aggregation in the World

Page 6 - Compass Pathways News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Compass Pathways. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Compass Pathways Today - Breaking & Trending Today

Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors - Vimarsana News

Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors

David Norton Assumes Role of Interim Board Chair while the Company Runs a Global Search for a New ChairLONDON, March 28, 2024 -- Compass Pathways plc , a biotechnology company dedicated to...

Compass Slips 7% As Chairman George Goldsmith, Co-Founder Ekaterina Malievskaia Step Down From Board - Vimarsana News

Compass Slips 7% As Chairman George Goldsmith, Co-Founder Ekaterina Malievskaia Step Down From Board

Shares of Compass Pathways plc (CMPS) are slipping over 7% after the company announced that board Chairman and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia will step down from the Board of Directors.

COMPASS Pathways (NASDAQ:CMPS) Sees Large Volume Increase - Vimarsana News

COMPASS Pathways (NASDAQ:CMPS) Sees Large Volume Increase

COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) saw an uptick in trading volume on Thursday . 358,701 shares traded hands during mid-day trading, a decline of 46% from the previous session’s volume of 666,186 shares.The stock last traded at $8.90 and had previously closed at $9.50. Analyst Ratings Changes Several research firms recently issued […]

Earnings Scheduled For February 29, 2024 - Arbutus Biopharma (NASDAQ:ABUS), American Coastal (NASDAQ:ACIC) - Vimarsana News

Earnings Scheduled For February 29, 2024 - Arbutus Biopharma (NASDAQ:ABUS), American Coastal (NASDAQ:ACIC)

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Compass Pathways Shares Tumble 18% After Warning of Trial Delay - Vimarsana News

Compass Pathways Shares Tumble 18% After Warning of Trial Delay

By Ben Glickman Shares of Compass Pathways sank Thursday after the company warned it was experiencing delays in one of its trials. The stock was down 18% to...